Waterhouse, David
Iadeluca, Laura
Sura, Sneha
Wilner, Keith
Emir, Birol
Krulewicz, Stan
Espirito, Janet
Bartolome, Lauren http://orcid.org/0000-0002-0649-2902
Funding for this research was provided by:
Pfizer
Article History
Accepted: 26 November 2021
First Online: 29 December 2021
Declarations
:
: The study was sponsored by Pfizer, Inc.
: Sneha Sura is an employee of Ontada, which was a paid consultant to Pfizer in connection with the development of this article. Janet Espirito is an employee of Ontada, which was a paid consultant to Pfizer in connection with the development of this article. David Waterhouse is an employee of OHC. OHC is an affiliate of US Oncology/McKesson McKesson, which was a paid consultant to Pfizer in connection with the development of this article.
: David Waterhouse has an advisory role/consulting from Bristol Myers Squibb, AZTherapies, AbbVie, Amgen, McGivney Global Advisors, Janssen Oncology, Seattle Genetics, Jazz Pharmaceuticals, Exelixis, Eisai, EMD Serono, Merck, Pfizer, Mirati Therapeutics, and Regeneron/Sanofi, speakers’ bureau from Bristol Myers Squibb, Janssen Oncology, Merck, AstraZeneca, and travel, accommodation and expenses from Bristol Myers Squibb. Laura Iadeluca is an employee of Pfizer, Inc. and owns stock in Pfizer, Inc. Sneha Sura is an employee of Ontada. Keith Wilner is an employee of Pfizer, Inc. and owns stock in Pfizer, Inc. Birol Emir is an employee of Pfizer, Inc. and owns stock in Pfizer, Inc. Janet Espirito is an employee of Ontada and owns stock in McKesson, which received consulting fees in connection with this study from Pfizer, Inc. Lauren Bartolome is an employee of Pfizer, Inc. and owns stock in Pfizer, Inc. Stan Krulewicz is an employee of Pfizer, Inc. and owns stock in Pfizer, Inc.
: Not applicable.
: The study protocol received an exception and waiver of informed consent from the US Oncology Institutional Review Board.
: Not applicable.
: Not applicable.
: Upon request, and subject to review, Pfizer will provide the data that support the findings of this study. Subject to certain criteria, conditions, and exceptions, Pfizer may also provide access to the related individual de-identified participant data. See ExternalRef removed for more information.
: Not applicable.